Tag: generic drugs

Marketing Impact: How Advertising Shapes Views of Generics

Explore how DTC advertising shapes patient views of generic drugs, creating bias towards branded medications through brand psychology and the spillover effect.

Health and Medicine

How Generic Drugs Are Made: The Manufacturing Process Explained

Discover how generic drugs are manufactured, from reverse engineering brand-name formulas to FDA-approved bioequivalence testing. Learn the steps, regulations, and quality controls that ensure generics are safe, effective, and affordable.

Health and Medicine

Medical Education on Generics: Do Doctors Learn Equivalence?

Doctors prescribe generics 90% of the time, but many still doubt their effectiveness. Why? Medical education focuses on brand names, not bioequivalence. Here’s what changes when training improves.

Health and Medicine

Medicare Part D Formularies: How Generic Coverage Works in 2026

Medicare Part D formularies prioritize generic drugs to lower costs, with Tier 1 generics often costing $0-$15. As of 2026, out-of-pocket spending is capped at $2,100 annually, with $0 costs after that. Understanding tier placement and annual formulary changes is key to saving money.

Health and Medicine

Serious Adverse Events: How to Report Generic Drug Reactions Correctly

Serious adverse events from generic drugs are underreported, creating dangerous blind spots in drug safety. Learn how to report them correctly, why the system fails, and what’s being done to fix it.

Health and Medicine

Cost-Effectiveness Analysis: How Generic Drugs Save Money Without Sacrificing Outcomes

Cost-effectiveness analysis shows how generic drugs save billions by offering the same health outcomes at a fraction of the price. Learn why some generics cost more than others-and how to spot real savings.

Health and Medicine

How Generic Drugs Save Billions in the U.S. Healthcare System

Generic drugs saved $482 billion in the U.S. healthcare system in 2024 alone. Learn how these affordable medications cut costs, improve access, and why the next wave of biosimilars could save trillions.

Health and Medicine